On Tuesday, Oscar Health earned a positive adjustment to its Relative Strength (RS) Rating, from 65 to 75.
This exclusive rating from Investor's Business Daily measures price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves. See if Oscar Health can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock manages to form a base and break out.
Oscar Health posted 0% EPS growth in its most recent report. Revenue gains came in at 68%.
The company earns the No. 5 rank among its peers in the Insurance-Accident & Healthcare industry group. Trupanion is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
